Inequities in access to biologic and synthetic DMARDs across 46 European countries

Polina Putrik; Sofia Ramiro; Tore K Kvien; Tuulikki Sokka; Milena Pavlova; Till Uhlig; Annelies Boonen; Working Group ‘Equity in access to treatment of rheumatoid arthritis in Europe’

doi:10.1136/annrheumdis-2012-202603

Article info

Clinical and epidemiological research

Extended report

Inequities in access to biologic and synthetic DMARDs across 46 European countries

Authors

Polina Putrik Department of Health Promotion and Education, Maastricht University, School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands PubMed articles Google scholar articles
Sofia Ramiro Department of Rheumatology, Hospital Garcia de Orta, Almada, Portugal; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articles Google scholar articles
Tore K Kvien Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway PubMed articles Google scholar articles
Tuulikki Sokka Department of Medicine, Jyväskylä Central Hospital, Jyvaskyla, Finland PubMed articles Google scholar articles
Milena Pavlova Department Health Services Research, CAPHRI, MUMC, Maastricht University, Maastricht, The Netherlands PubMed articles Google scholar articles
Till Uhlig National Research Center for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway PubMed articles Google scholar articles
Annelies Boonen Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and School for Public Health & Primary Care (CAPHRI), University Maastricht, Maastricht, The Netherlands PubMed articles Google scholar articles
Working Group ‘Equity in access to treatment of rheumatoid arthritis in Europe’
Google scholar articles

Correspondence to Polina Putrik, Department of Health Promotion and Education, Maastricht University, Peter Debyeplein 1, Maastricht 6229HA, The Netherlands; polina.putrik{at}gmail.com

View Full Text

Citation

Putrik P, Ramiro S, Kvien TK, et al

Inequities in access to biologic and synthetic DMARDs across 46 European countries

Annals of the Rheumatic Diseases 2014;73:198-206.

Publication history

Received August 31, 2012
Revised November 27, 2012
Accepted December 24, 2012
First published March 6, 2013.

Online issue publication

June 29, 2021

Article Versions

Previous version (29 June 2021).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password